Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GHY | 13.19 | 0.10 | +0.76% |
| PGIM Global High Yield Fund | |||
| FCTR | 30.13 | 0.01 | +0.02% |
| First Trust Lunt US Factor Rotation ETF | |||
| BSL | 14.10 | N/A | N/A |
| Blackstone Senior Floating Rate 2027 Term Fund | |||
| CSQ | 16.13 | -0.12 | -0.74% |
| Calamos Strategic Total Return | |||
| UGE | 19.16 | -0.58 | -2.93% |
| ProShares Ultra Consumer Staples | |||
A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.
| Ticker / NAME | Correlation To BEIGF | 1D Price Change % | ||
|---|---|---|---|---|
| BEIGF | 100% | N/A | ||
| GOVX - BEIGF | 29% Poorly correlated | -0.58% | ||
| CING - BEIGF | 29% Poorly correlated | -4.15% | ||
| CMRX - BEIGF | 27% Poorly correlated | +0.36% | ||
| POLBF - BEIGF | 25% Poorly correlated | N/A | ||
| TSVT - BEIGF | 11% Poorly correlated | +4.89% | ||
More | ||||